Ropivacaine 0.2%, and intravenous injection dexamethasone 8 mg (Group B)	Ropivacaine 0.2% alone (Group A)	Glucometric random blood sugar at 24 hours	10273	10393	Glucometric random blood sugar (GRBS) was significantly (P < 0.005) higher in Group B compared to Groups A and C at 24 h
Ropivacaine 0.2%, and intravenous injection dexamethasone 8 mg (Group B)	Ropivacaine 0.2% alone (Group A) 	Mean visual analog scale	10492	10589	VAS scores were significantly lower in Groups B and C at 8 h, 12 h, and 24 h compared to Group A.
Ropivacaine 0.2%, and intravenous injection dexamethasone 8 mg (Group B)	Ropivacaine 0.2% with injection dexamethasone 8 mg (Group C)	Glucometric random blood sugar at 24 hours	10273	10393	Glucometric random blood sugar (GRBS) was significantly (P < 0.005) higher in Group B compared to Groups A and C at 24 h
Ropivacaine 0.2%, and intravenous injection dexamethasone 8 mg (Group B)	Ropivacaine 0.2% with injection dexamethasone 8 mg (Group C)	Glucometric random blood sugar at 24 hours	10273	10414	Glucometric random blood sugar (GRBS) was significantly (P < 0.005) higher in Group B compared to Groups A and C at 24 h as shown in Table 2.
Ropivacaine 0.2% with injection dexamethasone 8 mg (Group C)	Ropivacaine 0.2% alone (Group A) 	Mean visual analog scale	1446	1539	The mean VAS was significantly lower in the Group C for up to 24 h following the caudal block
Ropivacaine 0.2% with injection dexamethasone 8 mg (Group C)	Ropivacaine 0.2% alone (Group A) 	Mean visual analog scale	10492	10589	VAS scores were significantly lower in Groups B and C at 8 h, 12 h, and 24 h compared to Group A.
